Lv4
410 积分 2023-04-18 加入
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
1天前
待确认
A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers
15天前
已完结
Linking tumour angiogenesis and tumour immunity
25天前
已完结
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
1个月前
已完结
Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)
1个月前
已完结
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)
1个月前
已完结
Immune profiling of pancreatic cancer for radiotherapy with immunotherapy and targeted therapy: Biomarker analysis of a randomized phase 2 trial
1个月前
已完结
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
6个月前
已完结
Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features
6个月前
已完结
TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages
7个月前
已完结
皖公网安备34019202002308
